Biological E is currently conducting the third phase trial of its anti- coronavirus vaccine named ‘Corbevax’. After the final results of the trial, the company will apply for its emergency use approval. It is expected that two doses of the vaccine may cost only Rs 500 or it can be priced below Rs 400. Mahima Datla, Managing Director of Biological E shared this information in an exclusive interview to Times of India. However, the final decision on its pricing is yet to be taken. At present, three vaccines, Covishield (Rs 300 per dose for state governments and Rs 600 per dose for private hospitals), Covaxin (Rs 400 and Rs 1,200) and Sputnik V (Rs 995 per dose), are being administered in India.
*Please create a profile first to EARN & REDEEM points
Biological E’s vaccine Corbevax likely to be priced at Rs 500 for two doses
We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.